Subhag products by Vikram Rajput bring new hope to childless couples

Business Remedies | Rajshree Upadhyaya |  Vikram Rajput’s journey towards founding Subhag began in the silence of personal heartache. Having endured multiple failed IVF cycles and facing the emotional stigma of infertility, he resolved to build something better than the status quo. His vision was to democratize reproductive care so that couples could access effective fertility solutions without navigating crippling costs or migration to distant clinics. Through that struggle, he found his purpose: to transform a deeply private challenge into a mission-driven venture.

In 2018 in Bengaluru, against a backdrop of modest resources and medical skepticism, Subhag HealthTech emerged. Drawing on collaborations between Indian reproductive health experts and German medical technologists, the founding team developed two core products after years of research: VConceive, a home-based intrauterine insemination (IUI) kit, and AndroWash, an automated sperm washing device. These were more than gadgets-they were components of a care ecosystem built to support couples with clinical guidance, privacy, and affordability.

The market Subhag entered was fraught with structural failure. Infertility affects an estimated 10-14 percent of Indian couples, but mainstream treatments remain prohibitively expensive, opaque, and fragmented. Vikram believed that the combination of social taboo and complex service delivery left a vast unmet need. Subhag’s pitch was that fertility support must be simplified, patient centric, and anchored in medical oversight. To that end, the company aimed not merely to sell devices, but to orchestrate a continuum: teleconsultations, diagnostic support, at-home procedural tools, and long-term monitoring.

When Subhag appeared on Shark Tank India, the moment felt like affirmation of that bold vision. The founders asked for capital to scale manufacturing tie up clinics and strengthen their regulatory footing. Namita Thapar accepted their offer, finalizing a deal where Subhag would offer 1 percent equity in return for a structured investment plus royalties. That validation on national television amplified awareness for the startup and reaffirmed the broader public that fertility tech could mix compassion and business.

After securing the deal, Subhag doubled down on credibility. It emphasized clinical validation, data-driven outcomes, and partnership with legitimate fertility centers. The leadership team-comprising Vikram as CEO, Sohan Sahu as COO, and medical advisors-pursued alignment with guidelines, patient safety, and transparency above rapid scale. Behind every product, the company sought trust: privacy for users, clear physician oversight, and rigorous process control.

Subhag’s evolution since the show illustrates how subtler metrics matter. Growth has not only meant more users or wider geographic reach, but stronger feedback loops from users, measurable success rates, and a sustainable operational model. The startup has worked to destigmatize infertility by openly promoting conversations and educating people about options. It has gradually forged alliances with clinics and labs to anchor its hybrid model of home plus in-clinic care.

Vikram’s original pain remains the compass for Subhag’s trajectory. His lived experience shapes decisions about pricing, support systems, and product iterations. That personal lens helps Subhag guard against becoming a cold tech vendor; instead, the startup frames itself as a partner in life’s hardest journeys. If the company can maintain that dual commitment to scientific rigour and emotional empathy, it may well help reshape how couples in India access reproductive care-not as a privilege but as supported possibility.

Written & Edited By:

Rajshree Upadhyaya